Form 4: Allovir CEO Diana Brainard Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Allovir's CEO, Diana Brainard, sold shares of common stock on August 5, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On August 5, 2024, Diana Brainard, the CEO of Allovir, Inc., sold 10,847 shares of Allovir's common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at prices ranging from $0.73 to $0.75, with a weighted average price of $0.7348.
- Following the transaction, Brainard directly owns 762,404 shares of Allovir common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (selling shares to cover taxes). It's neutral in sentiment.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 08/05/2024 | Date of stock sale transaction. |
| 08/07/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.